Bob, to you, earnings third thanks Thank today. joining call. our quarter welcome to everyone I’m pleased us and you for
detailed an our by CFO, extremely provide Rick Buchholz both and quarter of for third follow was some third one review detail a highlighted the with you The was U.S. and and us drove significant performance strong Inspire in progress quarter I’ll commercial strong the Europe. on financial. with what will
for the this Following will up your question. call open
maintaining market center. this focused strategy our implanting adoption of objective well primarily is centers, flow on growth the strong First and at increasing while patient I’d and the increase the existing to is as the to the mission Inspire of Therapy, With commercial awareness U.S. of in outcomes. training as new patient which with opening reinforce again mind, like Inspire team,
advancing and the in of In addition intend Inspire to in on growing we Europe reimbursement the have directing obtaining activities countries. established European countries process on key to market, both our reimbursement, continue of adoption that focus the while our other commercial Therapy U.S. product
that third significant Our top meaningful the $XX.X the increase $XX.X third quarter growth million, quarter for traction. the results the strategy of gaining for over same the was in worldwide same was year. The this XX% compared an revenue quarter prior a line the U.S. is of increase period year. prior million, of XX% to revenue quarter XXXX indicate
was representing in positive full of are robust these revenue European same strong on quarter XXXX million period results to $XX.X Based of XX% the million growth prior a up reflects and revised of year. a for from revenue $X.X guidance increasing increase Third to over approximately our $XX.X the year our the $XX of guidance XXX% we million. full year This prior over million to XXXX revenue $XX our revenue range million, to guidance of $XX.X million. XX% outlook,
factors on Let take this a the discuss primarily driving to initiative. drawn growth few that key ongoing me are U.S. minutes
are growth overview, these as increasing established responsible also centers, this implanting flow key of while individually, We number will an centers. enhancing first factors focus for but implanting patient the at the
patient third, Second, at open the driving approvals added further the of total while and U.S. have support our policies, continue prior focus Individually, currently new with XX third quarter, quarter the and We XXXX. in capacity the the coverage XXX managers centers quarter of then centers XX% implanting continue we number of of end positive third process. organization growth. the during more a the territory authorization obtaining to build this grow to on And with of individual to centers.
the period territory continue XX sales four organization, managers. managers which quarter, quarter total per a XX to seems XX we reminder, to we with target ending opening of centers added a As the to during territory new the
Our per the recruiting quarter third three mind, immediate two to These to to additional are to in nine addition to forward. With plans and add increase goal we this number the the a in the actively regional the is also internal we in as for by mix the two regional to with have promotion plant Vice four growth beginning of moving three four to regions, a bringing our organization balance reporting as President. represent regional of of of managers quarter XXXX, support the well managers new and business organization. consistent a managers total external reviewing our maintain TMs in area the capacity hired
We’re recruiting continually staff, outcomes. access including monitoring patient precise managers and intention all required therapy of with consistent positive representative, and facilitate clinical field and to implants training members, also additional achieving flow team surgical the support and
us therapy these in expect a and centers will growth maintain penetration growth balanced our overall with We in increased that impact new on territory help adoption. and at existing managers rate centers a have positive an will combination
Moving onto team. coverage This reimbursement. continues and the key have previously, expanding policies. have be reiterate we a we for known priority strategies market also to said two individual obtaining written access what authorization as To prior
prior the the these prior parallel. which authorization the number prior other we quarter an submitted is implant. therapy patient authorization submitted important the third regarding obtain is time individual individual likely we increase patient the factors time to quarter, method an – access is approvals. the authorization approval number from future XXX to In year. authorization, estimate second XXX overall of metric to to developed are and the First, Two approve in the track while rates prior The coverage patients are that in of policies the being submitted allow to of
of spent of walking XXXX. year-over-year process. compared to the authorization last call, also On time quarter prior increase third We XX% the a through little had I our earnings a
As includes a and to of complete. a cycle review takes three to reminder, four levels appeal oftentimes three full months
quarter. review three this We do cycle also or full some the cases? higher some rates want a coverage in of receive approved. start We companies to of the do level include their approval This submissions the solid them patients all we which noted to authorization the to simply change not process, through four that here from in mission Where further third improvement insurance XX%. attributable to approvals drop submitted the both wade positive decision and the as The largely increase right patients timing coverage have rate Aetna four of a in number off. that is process over. approximately The prior the as requires about quarter. earlier to contributed cases approval during XX% well issue the decision experienced do and prior overall months to these and for quarter, is to Other in appeal that of all authorizations these the was this not patients in
prior of the from fact, rate prior growth receive new was responsible of coverage authorization previously was first This is a In patients little Aetna of a Aetna half patients the authorization in end year. to the quarter XX% Aetna overall well both the third at impact than did review. of the up reported had in approval XX% the The quarter. the third a during not decision approximately for of as of more submitted increase third the at approvals the a combination who as
a third approvals XX% compared as the second XXXX quarter in and prior increase For this XXXX. the from cycles, about quarter, in the to who approval XXX% XX% to previously rate all of up XX%. increased a a we of in patients prior had appeals Moreover, experienced full reported of of third three number the quarter the over authorization approvals increase authorization review
closely, rates continue as to to submission continue other to the which will these add track approval. insurance coverage, time plants specifically We reduce from will
important and additional all decision believe closely of large for list will continue dossier on that ADHERE Inspire Now the a for Therapy, priority over Inspire Aetna other to procedure the make decision. regarding the XXX payers of year have are publication now To with study it that including XXXX the star supportive this clinical of follow we positive data the we peer date, we those also result. coverage five we to and foster payers their paid and working have the write of coverage – further work is policies. multitude that the plants update also own full for easier includes a decision and work with suit payers I communication An Therapy part focused
policy We are assessments decision. are that making their progress also important because conduct rely on technical agencies companies those assessments. with reviews the making in These insurance their external the technical
rating notified This an Inspire the which reviewed several evidence assessment a will favorably for example, is were is and Inspire from insurance C agency, has just rating to technical and This significant a company. upgraded a included improvement is reviews. yesterday, in in the a report, that Hayes, we As there again publications be actually clinical rating. DX not two the future upgrade were by viewed step promising which
example Street, Another a corporate which of technical Blue Blue is Cross Shield. group Evidence assessment is
would originally additional they recently detailed provide and one further Now, more that as time Street indicated until us they publish so notified subsequently month a delayed had delay, although a their of until the report July they only we findings that reported review. to in November, December. for Evidence
like coverage. from reconsideration also be move provide by as Shield their then sensor a Category pressure Blue to intended convert update Blue We original I Cross the region revise for CPT to now expect ranking, to towards add-on can this CPT the the group payers, a of which reviewed III we code. code Category on an would to the I
recall, reconsideration the Academy Meeting or overturned, that is Otolaryngology meeting the We a XXXX the meeting. for submitted The recommended resubmission American the at with AAO, the was AMA the September at you of February, in meeting. AMA heard application request AMA reconsideration May, the not As comment society. collaboration the but ENT was of was the application that denied and which
have and the submission for primary week. did to are and working that believe code the any AMA our the business, AAO with full code this provide the only the will in on We will remains sent to physician the term reimbursement hospital. the an this be place as XXXXX add-on this not impact payment CPT We is short new and
to the continue on progress back next process report year. will this We of early
statistically Inspire of a our submitted above life. web had evidence during There reaching near results of therapy, data, hour instrumental strategy. are therapy, quality the this a meeting ENT the for patients We our the real to have U.S. to the centers. the also held efficacy increase in of a per annual initiative Apnea-Hypopnea been the many younger improvement in activity mean comparing meeting, continue recent This Both a broaden the of Index groups direct-to-patient Inspire patient specifically we and which population we XXX therapy body Inspire in per commercial compared the in Atlanta. an very experience hour, number these months Medicare-aged that XX but the medical XX.X study that were at report world efforts compared but a the to XXXX. is on These X.X for for patients. to significant The groups in key continue to and initiatives was their therapy AHI, have and that with AHI demonstrated presentations cohort coverage have growing the leverage, was of or safety to study a plans experienced These an The health successful journal, this as significant to notably is U.S. addressed published growing we younger and add of implanting revaluation aspect and the reduction events prospective educating in as investigators therapy. AAO future. of be meeting, of to expect continue to is events of programs in these AHI leading both patients to correspond clinical most data to Medicare-aged these statistically effects population population. first compelling led in Commercially, The and as believe Inspire Medicare-aged Inspire on population. following a physician the of
in fact, approximately weekly XXXX, visitors web XX,XXX and averaged first In XX,XXX months we visitors on approximately the basis. engaged nine a of
to educate As last methods healthcare potential provider. patients identify on efficient tool I and continue improved said call, our we with to patients more see to connect
prospective with have recruited our over the patients. we’ll and in to the During with of quarter, individuals we direct-to-consumer the several third year marketing multiple next improve initiatives area education expertise
several of patient’s The Our to monitors system stimulation respiratory announced obstructions preventing patient’s pattern, to outcomes. sensing product while and work the Europe. significant lead FDA comfort. during therapy the hypoglossal of enhancing under continues sensor including clearance. and the the remember new reduction nerve a surgeon, also lead prior of The features sleep. new of pressure lead that XX% new sensing lead, delivery for by to pending experience, design have diameter of information patient development to team the implant the the maintaining to lead compared incorporates the implant in We also in approximately review Inspire lead the profile body of a sense Currently, ease a time providing the smaller is first our thereby recently uses lead improving as improve and the
be in the in the XXXX. first available half We States of expect the United product to
control the out the patient be the We improve programmer, and next parameters Inspire term, the Neurostimulator. have scoping other design projects of remote longer will underway we physician to generation
financials, like Rick his over progress Japan. in provide call the to review our the I’d on update of turn I before to So quick a for
and the at regulatory the of to and the sensing you review six the months that in approval The received is earlier could nine approval body system new PMDA. complete. system the version we Neurostimulator the As X for quarter, to recently know, take Inspire being Japan, approval end This the lead from was second the which we the PMDA. submitted of Inspire to for current
working consultants with societies define several program. the also to reimbursement Japan in and to We’re physician divide our
in Our scheme therapy reimbursement coordination coding current that be in in time will and of belief Japan this a entail is required will Inspire with authorities significant the for Japan. new
in late to this executed product in tell appropriate but and in In interim, we with is occur commercial XXXX, first implants launch. a Inspire recording anticipate there continue launch identify will to work XXXX. of to any the meaningful not do help Japan revenue that an expect We broader partner continue us Japan the to in
a our We as is strategy. key this initiating Asia-Pacific will continue for update, market to
the potential plan achieved includes evaluation have business excited strategic in also we our with opportunities the broader We’re working progress in summary, on that are then other by In a several of opportunities countries. meaningful the we remain.
highest possible generate the Our for to remains therapy primary goal outcome patients.
increase implanting centers We managers, further and reimbursement. development have on along number a quarterly to territories, with strategy of medical focus basis, growth and territory the
long that our term turn confident position to are We these like strategies for review that, of With financial. for to Rick? as detailed success. call the over I’d Rick well his
